WINDLAS BIOTECH LIMITED

Scale -

Revenue is 904 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 18 %
Ebitda is 123 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 20 %
PAT is 66.46 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 15 %
Quarterly Revenue is 238 Rs Cr; Continuous Growth over 3 Quarters
PBT is 20.16 Rs Cr; 5 Year CAGR is 18 %

Profitability -

PAT Margin is 7.35 %; Continuous Decline over 3 years

Return -

Asset Turnover is 108 %; in Top Quartile

ROCE is 15.65 %; Continuous Decline over 3 years
ROA is 7.33 %; Continuous Decline over 3 years
ROE is 11.46 %; Continuous Decline over 3 years

Efficiency -

Operating cash flow is 105 Rs Cr; Annual Growth is 54 %; 5 Year CAGR is 84 %
Inventory Turnover Ratio is 12.63; Continuous Growth over 3 years; in Top Quartile

Current Ratio is 1.95; Continuous Decline over 3 years
Quick Ratio is 1.76; Continuous Decline over 3 years

Solvancy -

Contingent Liabilities is 3.48 Rs Cr; Annual Growth is 67 %
Total Debt is 29.88 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 49 %
Debt/Equity is 0.05; 5 Year CAGR is 26 %

Quality -

Operating cashflow/ebitda is 86 %; Annual Growth is 41 %; 5 Year CAGR is 53 %
Operating cashflow/PAT is 158 %; Annual Growth is 41 %; in Top Quartile; 5 Year CAGR is 60 %
Other Expenses/Total Expenses is 11 %; in Bottom Quartile

Change in Inventories/Total Expenses is 1 %; Annual Growth is 128 %; in Top Quartile
Current Tax/PAT is 31 %; Continuous Growth over 3 years
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: